GlassScriptPhysician profile
David K Oleary
NPI 1578539334
$1,182.38
in general payments reported to CMS, 2019-2025
8 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $14.59 · 2021: $36.38 · 2022: $380 · 2023: $124 · 2024: $31.44 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387 · Entertainment: $30.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.43 |
| Entertainment | $30.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $376.27 | 2022-2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $266.18 | 2019 | |
| Alcon Vision LLC | $192.85 | 2020-2024 | Total30 |
| Abbvie INC. | $124.98 | 2025 | |
| Allergan, INC. | $124.54 | 2022 | |
| Amniox Medical, INC. | $52.00 | 2019 | |
| Optos, INC. | $30.74 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.